Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease breast cancer
Symptom C0494165|liver metastasis
Sentences 24
PubMedID- 25510782 Does liver resection provide long-term survival benefits for breast cancer patients with liver metastasis.
PubMedID- 24520229 reported that hepatic capsular retraction in breast cancer with liver metastasis was associated with larger metastases and both an increase and a decrease in the size of subjacent lesions.
PubMedID- 23691457 Survival analysis of breast cancer patients with liver metastasis.
PubMedID- 24731490 Conclusion: age and response to treatment are independent prognostic factors for er and/or pr positive breast cancer patients with liver metastasis.
PubMedID- 21918348 We experienced 3 cases of anti-cancer drug-resistant recurrent breast cancer with liver metastasis showing significant improvement by s-1.
PubMedID- 24550602 Liver resections of isolated liver metastasis in breast cancer: results and possible prognostic factors.
PubMedID- 22212746 Biopsy of liver metastasis for women with breast cancer: impact on survival.
PubMedID- 22111550 We have shown that smad7, an i-smad that inhibits tgf-β and bmp signaling, efficiently inhibits lung and liver metastasis of mouse breast cancer jygmc(a) cells (39).
PubMedID- 24528110 Conclusions: our results indicate that vinorelbine and capecitabine have different advantageous effects in breast cancer patients with lung/liver metastasis.
PubMedID- 20332693 A case of recurrent breast cancer with life-threatening liver metastasis remarkably responding to classical cmf.
PubMedID- 23631392 Selenium nanoparticle-enriched lactobacillus brevis causes more efficient immune responses in vivo and reduces the liver metastasis in metastatic form of mouse breast cancer.
PubMedID- 26290278 Real-world effectiveness of everolimus-based therapy versus endocrine monotherapy and chemotherapy in patients of hr+/her2- breast cancer with liver metastasis in the usa.
PubMedID- 26131799 Kaplan–meier analysis of progression-free survival (pfs) among breast cancer patients with lung or liver metastasis (p = 0.037).
PubMedID- 23382998 We demonstrated that over-expression of nucleus ki67 at the invasive front in breast cancer is associated with bone and liver metastasis.
PubMedID- 20567114 Long-term survival of a breast cancer patient with liver metastasis treated with trastuzumab and paclitaxel.
PubMedID- 26250702 Objective: this study investigated the comparative effectiveness of everolimus-based therapy (eve) versus endocrine monotherapy (et) and chemotherapy (ct) in the treatment of hormone-receptor-positive human-epidermal-growth-factor-receptor-2-negative (hr+/her2-) metastatic breast cancer (mbc) patients with liver metastasis.
PubMedID- 22568985 During this process it has been shown that smad7 and i-smad that inhibits tgfβ1 and bone morphogenetic protein signaling, efficiently inhibits lung and liver metastasis of mouse breast cancer jygmc(a) cells.156 smad7 also inhibited the migration and invasion of cells, indicating that smad7 leads to prevention of the emt process.156 all these strategies principally aim in inhibiting later effects of the already active tgfβ1 during tumor formation and preventing metastasis of advanced cancers.
PubMedID- 25974184 This mimics clinical observation that demonstrates a higher percentage of lung metastasis than liver metastasis in patients with breast cancer .
PubMedID- 25731390 We managed two cases of esophageal variceal rupture during chemotherapy for breast cancer with liver metastasis.
PubMedID- 24708527 The survival rate of breast cancer patients with isolated liver metastasis who have undergone liver resection has dramatically increased due to medical advances and multidisciplinary care: improved chemotherapy and targeted agents, more effective surgery and better post-operative care.
PubMedID- 22996777 Trastuzumab and chemoendocrine therapy showed efficacy for the treatment of a her2-positive breast cancer with recurrent giant liver metastasis.
PubMedID- 26496295 These imaging results indicate liver metastasis of breast cancer (arrows indicate lesions).
PubMedID- 22720210 Nk cells were abundant in non malignant lung tissues and displayed high cytotoxic activity compared with nk cells in mlta.48 a similar alteration in nk cell distribution was also recently found between normal liver tissue and liver metastasis of crc.41 in breast cancers, the number of nk cells in malignant tissue is reduced and includes a higher percentage of cd56bright compared with healthy mammary tissue.
PubMedID- 26416044 Hepatic steatosis is associated with higher incidence of liver metastasis in patients with metastatic breast cancer; an observational clinical study.

Page: 1